Press Releases

Remedium and Exothera partner on scale-up and demonstration runs for AAV2-FGF18

Remedium Bio and Exothera S.A. reached an agreement for a collaboration to demonstrate the industrialization potential of Remedium’s AAV2-FGF18.

The Working Principle and Applications of Ion Exchange Resin

CD Formulation Supplies Active Ingredients, Antioxidants, and Chelating Chemicals for Cosmetic Industry

Sustainability takes centre stage for Tower Cold Chain at LogiPharma

Temperature-controlled specialist Tower is returning to LogiPharma in 2023 to showcase how pharmaceutical manufacturers are using its passive containers to improve their logistics infrastructure, in today’s sustainably inclined world.

Clinical Pharmacology of Antibody-Drug Conjugates

Biotech lab TruDiagnostic and NADMED partner to launch novel NAD blood test in United States

NADMED has announced that TruDiagnostic partner to launch novel NAD blood test in the United States.

Inizio strengths senior team with DE&I appointment

International strategic health and life science specialists Inizio have increased their organizational-wide focus on diversity, equity, and inclusion with the appointment of Stefanie Christmas as their new Global Head of Diversity, Equity & Inclusion (DE&I).

Life Science and Healthcare Industry Executive Adam Deutsch Joins uMotif Board as Company Brings the Next-Generation of eCOA/ePRO to Expanding Global Market

Adam Deutsch has a proven track record of leading major transformations in global life sciences and MedTech businesses; renowned for deep domain expertise, and for excellence in high-level operational, functional and compliance roles at public and private companies

BioIVT to Highlight its Drug-Drug Interaction and ADME Research Expertise at the SOT Annual Meeting and ToxExpo

BioIVT’s goal is to be the trusted partner for in vitro research, whether it is providing hepatic products for internal programs or designing and implementing research in its labs.

Clinical Trial Technology Trends: The Top 5 Innovations Shaping Clinical Trials in 2023

Discover the top 5 clinical trial technology trends in 2023. From wearables to AI, Digital Patient engagement tools and techniques that are shaping the future of clinical research

Mural Health and ProofPilot Partner to Streamline Payments and Provide More Patient Choice

Mural Health, a clinical trials technology company that improves the patient and caregiver experience in order to improve enrollment rates, participant retention, and increase protocol compliance and ProofPilot, the industry's first digital protocol automation platform for clinical trial, today announced a strategic partnership to further advance clinical trial operations for life science customers. Through this partnership, Mural Health’s Mural Link™ platform and ProofPilot’s platform work together to progress clinical operations and materially improve the efficiency, and outcomes, of global clinical trials.

Clinion Launches Revolutionary AI-Powered Medical Coding Solution for Clinical Trials

[London, UK] - Clinion, a leading provider of eClinical solutions, has announced the launch of its new AI-powered medical coding solution. This innovative solution is designed to transform the medical coding process for clinical trials, offering a faster, more efficient, and more accurate way to code medical data.

NDA Group announces expansion of its Advisory Board adding expertise in bioanalysis and immunogenicity assessment

NDA Group is thrilled to announce the expansion of their Advisory Board with the appointment of Marianne Scheel Fjording, Ph.D.

Optical Brighteners, Plasticizers, and Antioxidants as Polymer Stabilizers

Biopharma PEG To Attend PEGS Boston Summit 2023

Huateng Pharma Announced To Present CPhI North America In April 2023

Curebase Selected Among Y Combinator’s Top Private Companies of 2023

DCT platform company places in top 6% of private companies; recognized for end-to-end clinical trial execution built on cutting-edge software

CD ComputaBio Introduces AutoDock, a Powerful Molecular Docking Software

TransCure bioServices delivers CDX mouse models to advance AML preclinical studies

TransCure bioServices has developed cell line-derived xenograft (CDX) mouse models that will change how researchers tackle the preclinical studies of cancer therapies to treat acute myeloid leukemia (AML).

Creative Enzymes Releases Restriction Enzymes for Molecular Biology Research